On March 23, 2017, RMMS was awarded a Managing Intellectual Property Firm of the Year Award as the 2017 “U.S. Firm to Watch.” The award recognizes RMMS’s broad success representing numerous national and international clients in Hatch-Waxman litigation, regulatory counseling and litigation, and counseling and litigation in connection with the Biologics Price Competition and Innovation Act (BPCIA).
Managing Intellectual Property announced the recipients of the “Firm of the Year" awards at its 2017 North American Intellectual Property awards ceremony in Washington, DC. Several members of the RMMS team were on hand for the awards ceremony, and Founding Partner Deanne Mazzochi accepted the 2017 “U.S. Firm to Watch” award on behalf of RMMS.
Managing Intellectual Property's annual Firm of the Year awards recognize firms who have made outstanding contributions to IP work over the past year, based on Managing IP’s annual research into the IP market, including reference to publicly available information, client and peer comments. Winners of the 2017 North American Intellectual Property awards will be featured in the May edition of Managing Intellectual Property.
Based in Chicago, Illinois, RMMS is the only specialty litigation and counseling boutique in the United States devoted exclusively to the pharmaceutical, biologic, and life sciences industries. Our experience and our record of success are second to none. Since 2004, RMMS has handled more than 250 Hatch-Waxman and related pharmaceutical (DJ/patent infringement, APA, and commercial) matters involving at least 135 different drug products for at least twenty pharmaceutical companies. RMMS has been recognized four years in a row as one of the top Hatch-Waxman litigation firms in the country by LMG Life Sciences, which commented that RMMS “is seen as a top of-the-line IP litigation firm by peers within the industry. Rakoczy Molino is considered by its competitors as a dark horse candidate as the best Hatch-Waxman litigation firm in the country.”